SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 365.26 |
| Enterprise Value ($M) | 318.45 |
| Book Value ($M) | 121.73 |
| Book Value / Share | 1.89 |
| Price / Book | 3.00 |
| NCAV ($M) | -38.20 |
| NCAV / Share | -0.59 |
| Price / NCAV | -9.56 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.35 |
| Return on Assets (ROA) | -0.26 |
| Return on Equity (ROE) | -0.82 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.14 |
| Current Ratio | 3.14 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 149.30 |
| Assets | 309.24 |
| Liabilities | 187.50 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 14.02 |
| Operating Income | -137.06 |
| Net Income | -84.03 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -105.36 |
| Cash from Investing | 34.03 |
| Cash from Financing | 84.02 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | Perceptive Advisors Llc | 18.00 | 0.32 | |
| 13G/A | Prosight Management, LP | 6.40 | -0.69 | |
| 13G/A | Adage Capital Partners Gp, L.l.c. | 8.32 | 70.38 | |
| 13G | Sanofi | 7.40 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 13,072 | 57,629 | 22.68 | |
| 28,395 | 65,627 | 43.27 | |
| 22,465 | 159,588 | 14.08 | |
| 15,855 | 96,020 | 16.51 | |
| 14,225 | 80,045 | 17.77 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| MCRB – Seres Therapeutics, Inc. | MDGL – Madrigal Pharmaceuticals, Inc. |
| MGNX – MacroGenics, Inc. | MIST – Milestone Pharmaceuticals Inc. |
| MLYS – Mineralys Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io